Compare 10X Genomics Inc (TXG) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Yum! Brands, Inc. — how do they compare? 10X Genomics Inc trades at $67.16 (market cap $8.77B), while Yum! Brands, Inc. trades at $146.9 (market cap $39.61B). The key difference: Yum! Brands, Inc. is far larger — about 4.5× 10X Genomics Inc's market cap, and Yum! Brands, Inc. pays a 2.07% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | YUM | |
|---|---|---|
Market Cap | $8.77B | $39.61B |
Sector | Health | Consumer Cyclical |
52-Week High | $67.29 | $168.16 |
52-Week Low | $11.34 | $138.21 |
Enterprise Value | $8.29B | $51.22B |
Dividend Yield | — | 2.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TXG trades at $65.60, up 4.71% today, with a bullish technical signal and recent earnings beats. The stock shows improving fundamentals, with 2025 revenue at $642.82M and net loss narrowing to -$43.54M. Positive sentiment is driven by patent wins, Atera platform demand, and institutional interest, though valuation metrics like P/S of 13.58 and EV/EBITDA of 142.2 remain elevated.
Outlook is cautiously optimistic with upside potential from Atera execution, but risks include high valuation, persistent losses, and competitive pressures. Analyst consensus is mixed with a $50.56 price target below current levels, indicating near-term caution despite long-term growth prospects in genomics.
YUM trades at $149.59, down 0.74% on the day, with a bearish technical signal from moving averages. The company reported revenue of $8.21B in 2025, with net income of $1.56B and a net margin of 25.4%. Recent developments include the sale of Pizza Hut for approximately $1.5B to LongRange Capital, completed on September 1, 2026, and a declared quarterly dividend of $0.75 per share. Analyst consensus is a buy rating with a price target of $173.60, though technical indicators suggest near-term caution.
Outlook remains supported by strong profitability and strategic portfolio optimization, but risks include high debt levels and competitive pressures. The stock offers potential upside to the consensus target, yet investor sentiment is mixed amid broader market volatility and recent insider selling.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
